Esomeprazole Magnesium
Product Images NDC 50090-3903

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-3903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Esomeprazole Magnesium Delayed Release Capsules Us 1)

Chemical structure of esomeprazole magnesium, showing two esomeprazole molecules complexed with a magnesium ion (Mg2+) and associated with two water molecules (dihydrate). The structure includes methoxy groups and heterocyclic rings characteristic of esomeprazole.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Magnesium Delayed Release Capsules Us 2)

A line graph depicting percent maintained over 6 months for Esomeprazole Magnesium Delayed-release Capsules at doses of 40 mg, 20 mg, and 10 mg versus placebo. The x-axis represents months with scheduled visits, and the y-axis indicates percent maintained, showing higher maintenance rates with increasing dose compared to placebo.*

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Magnesium Delayed Release Capsules Us 3)

A line chart showing the percent maintained over 6 months for Esomeprazole Magnesium Delayed-release Capsules at 40 mg, 20 mg, 10 mg, and a placebo group. The x-axis represents time in months with scheduled visits, and the y-axis represents percent maintained. The 40 mg group shows the highest maintenance rate, followed by the 20 mg, 10 mg, and placebo groups respectively.*

FDA Label Image

Figure 4 (Esomeprazole Magnesium Delayed Release Capsules Us 4)

A line chart showing the percent of patients symptom-free over 28 diary days comparing esomeprazole magnesium delayed-release capsules 40 mg, 20 mg, and placebo. The vertical axis represents the percent of patients symptom-free, and the horizontal axis represents diary days from 0 to 28. Three distinct lines correspond to the 40 mg dose, 20 mg dose, and placebo groups, demonstrating trends in symptom relief over time.*

FDA Label Image

Figure 5 (Esomeprazole Magnesium Delayed Release Capsules Us 5)

A line chart showing the percentage of patients symptom-free over a 28-day diary period. The chart compares Esomeprazole Magnesium Delayed-release Capsules 40 mg, 20 mg, and placebo, with time in days on the x-axis and percent symptom-free patients on the y-axis. Higher doses show greater symptom-free percentages over time.*

FDA Label Image

Label Image (Lbl500903903)

Esomeprazole Magnesium 20 mg label from A-S Medication Solutions, LLC, NDC 50090-3903. The label indicates 30 delayed-release capsules, with storage instructions at 77 degrees Fahrenheit. The lot number, product number, and a QR code for dosage information are also visible on the white label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.